These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36419100)

  • 1. Synthesis, biological evaluation, and computational studies of some novel quinazoline derivatives as anticancer agents.
    Emami L; Khabnadideh S; Faghih Z; Farahvasi F; Zonobi F; Gheshlaghi SZ; Daili S; Ebrahimi A; Faghih Z
    BMC Chem; 2022 Nov; 16(1):100. PubMed ID: 36419100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Bromo quinazoline derivatives as cytotoxic agents: design, synthesis, molecular docking and MD simulation.
    Emami L; Hassani M; Mardaneh P; Zare F; Saeedi M; Emami M; Khabnadideh S; Sadeghian S
    BMC Chem; 2024 Jul; 18(1):125. PubMed ID: 38965630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, computational study and cytotoxic evaluation of some new quinazoline derivatives containing pyrimidine moiety.
    Zare S; Emami L; Faghih Z; Zargari F; Faghih Z; Khabnadideh S
    Sci Rep; 2023 Sep; 13(1):14461. PubMed ID: 37660139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents.
    Emami L; Sadeghian S; Mojaddami A; Khabnadideh S; Sakhteman A; Sadeghpour H; Faghih Z; Fereidoonnezhad M; Rezaei Z
    BMC Chem; 2022 Nov; 16(1):91. PubMed ID: 36369166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of some novel dibromo-2-arylquinazolinone derivatives as cytotoxic agents.
    Faghih Z; Rahmannejadi N; Sabet R; Zomorodian K; Asad M; Khabnadideh S
    Res Pharm Sci; 2019 Apr; 14(2):115-121. PubMed ID: 31620187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of 2,3-dihydro-[1,4]dioxino[2,3-f]quinazoline derivatives as EGFR inhibitors.
    Qin X; Yang L; Liu P; Yang L; Chen L; Hu L; Jiang M
    Bioorg Chem; 2021 May; 110():104743. PubMed ID: 33714020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and cytotoxic evaluation of quinazoline derivatives bearing triazole-acetamides.
    Pedrood K; Taayoshi F; Moazzam A; Iraji A; Yavari A; Ansari S; Sajjadi-Jazi SM; Mohajeri-Tehrani MR; Garmsiri N; Haghpanah V; Soleymanibadi M; Larijani B; Hamedifar H; Adibpour N; Mahdavi M
    Heliyon; 2023 Feb; 9(2):e13528. PubMed ID: 36873155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some novel hybrid quinazoline-based heterocycles as potent cytotoxic agents.
    Malekzadeh M; Dadkhah S; Khodarahmi GA; Asadi P; Hassanzadeh F; Rostami M
    Res Pharm Sci; 2022 Feb; 17(1):22-34. PubMed ID: 34909041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, molecular docking, and cytotoxicity of quinazolinone and dihydroquinazolinone derivatives as cytotoxic agents.
    Taayoshi F; Iraji A; Moazzam A; Soleimani M; Asadi M; Pedrood K; Akbari M; Salehabadi H; Larijani B; Adibpour N; Mahdavi M
    BMC Chem; 2022 May; 16(1):35. PubMed ID: 35585608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
    Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
    Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinazoline analogues as cytotoxic agents; QSAR, docking, and
    Emami L; Sabet R; Khabnadideh S; Faghih Z; Thayori P
    Res Pharm Sci; 2021 Oct; 16(5):528-546. PubMed ID: 34522200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.
    Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A
    Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Hydrazone Derivatives of 3-Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies.
    Beygi F; Mostoufi A; Mojaddami A
    Chem Biodivers; 2022 Jun; 19(6):e202100754. PubMed ID: 35427437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro anticancer evaluation of some fused indazoles, quinazolines and quinolines as potential EGFR inhibitors.
    Abdelsalam EA; Zaghary WA; Amin KM; Abou Taleb NA; Mekawey AAI; Eldehna WM; Abdel-Aziz HA; Hammad SF
    Bioorg Chem; 2019 Aug; 89():102985. PubMed ID: 31121559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization, molecular docking, antimalarial, and antiproliferative activities of benzyloxy-4-oxopyridin benzoate derivatives.
    Mohebi M; Fayazi N; Esmaeili S; Rostami M; Bagheri F; Aliabadi A; Asadi P; Saghaie L
    Res Pharm Sci; 2022 Jun; 17(3):252-264. PubMed ID: 35531137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2.
    Alkahtani HM; Abdalla AN; Obaidullah AJ; Alanazi MM; Almehizia AA; Alanazi MG; Ahmed AY; Alwassil OI; Darwish HW; Abdel-Aziz AA; El-Azab AS
    Bioorg Chem; 2020 Jan; 95():103461. PubMed ID: 31838290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics.
    Lu Y; Yin W; Alam MS; Kadi AA; Jahng Y; Kwon Y; Rahman AFMM
    Anticancer Agents Med Chem; 2020; 20(4):464-475. PubMed ID: 31763968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.